Approach to the patients with the hallucinations, in the Parkinson’s disease in the low-income country and environment of restricted medications and stigmas
Objective: Expose the percentage of patients with hallucinations in studying group of Parkinson’s disease patients in Uzbekistan. Background: Uzbekistan has 35 million population, largest in…Antipsychotics Use in Parkinson’s Disease and Mortality Risks
Objective: To describe the use of antipsychotics in patients with Parkinson’s disease (PD) and study its associated mortality risks. Background: The US Food and Drug…Delusional Misidentification Syndrome for “Self” in two patients with Parkinson`s Disease.
Objective: We report two patients with Parkinson’s disease(PD) and Capgras syndrome (CS) with confusion of identify not just of close acquaintances but also of “self”.…Neuroleptic medication is associated with a worse health status in the years prior to treatment, but have the potential for normalization
Objective: To determine the interval between impact on health-related quality of life (HRQL) and initiation of treatment with neuroleptics in patients with Parkinson's disease (PD)…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.